John Philip  Jones net worth and biography

John Jones Biography and Net Worth

Mr. Jones has been our Chief Financial Officer since January 2, 2019. From August 2016, he served as the Company’s VP Finance and Assistant Corporate Secretary and joined Alimera in June of 2015 as Corporate Controller. Prior to Alimera, Mr. Jones held various senior financial leadership roles in Theragenics Corporation, a medical product manufacturing company, Superior Essex, a communications cable company, and Arjo Wiggins Medical, the medical materials division of Arjo Wiggins Appleton. Mr. Jones began his financial career in 1986 as an accountant for a large regional CPA firm in Atlanta, Georgia. Mr. Jones is a Certified Public Accountant in the state of Georgia and is a graduate of Auburn University with a B.S.B.A. degree with an emphasis in accounting.

How do I contact John Philip Jones?

The corporate mailing address for Mr. Jones and other Alimera Sciences executives is 6120 WINDWARD PARKWAY STE 290, ALPHARETTA GA, 30005. Alimera Sciences can also be reached via phone at (678) 990-5740 and via email at [email protected]. Learn More on John Philip Jones' contact information.

Has John Philip Jones been buying or selling shares of Alimera Sciences?

John Philip Jones has not been actively trading shares of Alimera Sciences during the last ninety days. Most recently, on Wednesday, November 3rd, John Philip Jones bought 5,000 shares of Alimera Sciences stock. The stock was acquired at an average cost of $4.08 per share, with a total value of $20,400.00. Learn More on John Philip Jones' trading history.

Who are Alimera Sciences' active insiders?

Alimera Sciences' insider roster includes Philip Ashman (COO), Richard Eiswirth, Jr. (CEO), John Jones (CFO), and James Largent (Director). Learn More on Alimera Sciences' active insiders.

Are insiders buying or selling shares of Alimera Sciences?

During the last year, Alimera Sciences insiders bought shares 1 times. They purchased a total of 579,000 shares worth more than $1,962,810.00. The most recent insider tranaction occured on September, 14th when Major Shareholder Caligan Partners Lp bought 579,000 shares worth more than $1,962,810.00. Insiders at Alimera Sciences own 31.4% of the company. Learn More about insider trades at Alimera Sciences.

Information on this page was last updated on 9/14/2023.

John Philip Jones Insider Trading History at Alimera Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/3/2021Buy5,000$4.08$20,400.00View SEC Filing Icon  
12/10/2019Buy1,000$9.44$9,440.00
See Full Table

John Philip Jones Buying and Selling Activity at Alimera Sciences

This chart shows John Philip Jones's buying and selling at Alimera Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alimera Sciences Company Overview

Alimera Sciences logo
Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. It operates through United States, International, and Operating Cost segments. The company offers ILUVIEN, a fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). It also provides YUTIQ, a fluocinolone acetonide intravitreal implant to treat NIU-PS. The company sells its products to physician offices, clinics, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. to develop, manufacture, and sell products including YUTIQ for the treatment and prevention of uveitis; and Ocumension (Hong Kong) Limited for the development and commercialization of the company's 190 microgram fluocinolone acetonide intravitreal implant in applicator for the treatment and prevention of eye diseases. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Read More

Today's Range

Now: $3.05
Low: $3.02
High: $3.27

50 Day Range

MA: $3.31
Low: $2.89
High: $3.85

2 Week Range

Now: $3.05
Low: $2.60
High: $4.38

Volume

86,900 shs

Average Volume

166,428 shs

Market Capitalization

$159.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14